Evidence map›Paper›PMID 42110076›Full record

ArticleCureus2026

Concurrent Superior Mesenteric and Splenic Vein Thrombosis in a Prothrombin G20210A Carrier: Radiologic Evolution and Resolution on Apixaban.

Christopher M Ahmad, Rae-Anne Kastle, Niki Gharavi Alkansari, Phil T Sheridan, Samir Dalia

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Christopher M AhmadInternal Medicine, Kansas City University, Joplin, USA.
Rae-Anne KastleEmergency Medicine, Kansas City University, Joplin, USA.
Niki Gharavi AlkansariInternal Medicine, Kansas City University, Joplin, USA.
Phil T SheridanInternal Medicine, Kansas City University, Joplin, USA.
Samir DaliaInternal Medicine/Hematology, Mercy Hospital Joplin, Joplin, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Splanchnic venous thrombosis (SVT) is an uncommon vascular condition that may occur in association with liver disease, malignancy, or intra-abdominal inflammatory processes. In cases where these conditions are absent, and SVT occurs as a primary disease process, an underlying thrombophilic predisposition should be considered. Concurrent involvement of the superior mesenteric and splenic veins in this context is uncommon and may suggest an inherited prothrombotic tendency. We describe a 76-year-old man with a known heterozygous prothrombin G20210A mutation who presented with several days of abdominal discomfort and was found to have non-occlusive thrombosis of the superior mesenteric vein extending into the splenic vein. Contrast-enhanced computed tomography (CT) confirmed the diagnosis, and a structured evaluation, including positron emission tomography (PET)-CT and comprehensive hypercoagulable testing, excluded malignancy and other acquired causes. Anticoagulation with apixaban was initiated, and follow-up imaging at three months demonstrated complete radiographic resolution. The patient remained clinically stable without bleeding or recurrent thrombosis at six months. This case highlights the importance of systematic etiologic evaluation in non-cirrhotic SVT and illustrates how an inherited thrombophilic predisposition, such as heterozygous prothrombin G20210A mutation, may contribute to thrombosis in the appropriate clinical context.

Indexed as

doacinherited thrombophiliasprothrombin g20210a mutationsplanchnic venous thrombosissuperior mesenteric and splenic vein thromboses

Identifiers

PMID42110076
PMCPMC13157197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.